Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00985
|
|||||
| Drug Name |
Cyproterone
|
|||||
| Synonyms |
(1R,3aS,3bR,7aR,8aS,8bS,8cS,10aS)-1-acetyl-5-chloro-1-hydroxy-8b,10a-dimethyl-2,3,3a,3b,7a,8,8a,8b,8c,9,10,10a-dodecahydrocyclopenta[a]cyclopropa[g]phenanthren-7(1H)-one; 6-Chlor-delta(6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron; 6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron; 6-Chlor-delta(sup 6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron [German]; 6-chloro-17-hydroxy-1beta,2beta-dihydro-3'H-cyclopropa[1,2]pregna-4,6-diene-3,20-dione; Apo-cyproterone; Ciproterona; Ciproterona Servycal; Ciproterona Servycal (TN); Ciproterona [INN-Spanish]; Ciproterone; Ciproterone [DCIT]; CyPat; Cyproteron; Cyproterone (INN); Cyproterone [INN:BAN]; Cyproteronum; Cyproteronum [INN-Latin]; Diane-35 (TN); Dianette (TN); Gen-Cyproterone; Novo-cyproterone; SH 80881
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H27ClO3
|
|||||
| Canonical SMILES |
CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)O
|
|||||
| InChI |
InChI=1S/C22H27ClO3/c1-11(24)22(26)7-5-14-12-9-18(23)17-10-19(25)13-8-16(13)21(17,3)15(12)4-6-20(14,22)2/h9-10,12-16,26H,4-8H2,1-3H3/t12?,13-,14?,15?,16+,20?,21?,22+/m1/s1
|
|||||
| InChIKey |
DUSHUSLJJMDGTE-LXMMIWJPSA-N
|
|||||
| CAS Number |
CAS 2098-66-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 374.9 | Topological Polar Surface Area | 54.4 | ||
| Heavy Atom Count | 26 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
3.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:50742
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.